Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate

The public health burden of Alzheimer’s disease (AD) is related not only to cognitive symptoms, but also to neuropsychiatric symptoms, including apathy. Apathy is defined as a quantitative reduction of goal-directed activity in comparison to a previous level of functioning and affects 30%–70% of per...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dyck, Christopher H., Arnsten, Amy F.T., Padala, Prasad R., Brawman-Mintzer, Olga, Lerner, Alan J., Porsteinsson, Anton P., Scherer, Roberta W., Levey, Allan I., Herrmann, Nathan, Jamil, Nimra, Mintzer, Jacobo E., Lanctôt, Krista L., Rosenberg, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641967/
https://www.ncbi.nlm.nih.gov/pubmed/32461027
http://dx.doi.org/10.1016/j.jagp.2020.04.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641967/
https://www.ncbi.nlm.nih.gov/pubmed/32461027
http://dx.doi.org/10.1016/j.jagp.2020.04.026

Ejemplares similares